289 related articles for article (PubMed ID: 9661615)
1. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist.
Klein KO; Baron J; Barnes KM; Pescovitz OH; Cutler GB
J Clin Endocrinol Metab; 1998 Jul; 83(7):2387-9. PubMed ID: 9661615
[TBL] [Abstract][Full Text] [Related]
2. Effect of deslorelin dose in the treatment of central precocious puberty.
Pescovitz OH; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
[TBL] [Abstract][Full Text] [Related]
3. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
[TBL] [Abstract][Full Text] [Related]
4. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
5. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
6. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
7. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
8. Adult height in precocious puberty after long-term treatment with deslorelin.
Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
[TBL] [Abstract][Full Text] [Related]
9. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
Garibaldi LR; Aceto T; Weber C; Pang S
J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
[TBL] [Abstract][Full Text] [Related]
11. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
[TBL] [Abstract][Full Text] [Related]
12. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment?
Kunz GJ; Sherman TI; Klein KO
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1189-98. PubMed ID: 18183790
[TBL] [Abstract][Full Text] [Related]
14. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
[TBL] [Abstract][Full Text] [Related]
16. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.
Lahlou N; Roger M; Chaussain JL; Feinstein MC; Sultan C; Toublanc JE; Schally AV; Scholler R
J Clin Endocrinol Metab; 1987 Nov; 65(5):946-53. PubMed ID: 2959680
[TBL] [Abstract][Full Text] [Related]
18. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
[TBL] [Abstract][Full Text] [Related]
19. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
20. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
Feuillan PP; Jones J; Cutler GB
J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
